GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $607,000 | +4.1% | 14,084 | -7.7% | 0.07% | +15.8% |
| Q3 2021 | $583,000 | -5.4% | 15,255 | -1.4% | 0.06% | -8.1% |
| Q2 2021 | $616,000 | +20.8% | 15,476 | +11.1% | 0.06% | +5.1% |
| Q1 2021 | $510,000 | -2.1% | 13,929 | -4.3% | 0.06% | -6.3% |
| Q4 2020 | $521,000 | -16.6% | 14,560 | -96.0% | 0.06% | -44.2% |
| Q3 2020 | $625,000 | -20.1% | 364,129 | -0.7% | 0.11% | -32.3% |
| Q2 2020 | $782,000 | -26.9% | 366,513 | -1.7% | 0.17% | -34.5% |
| Q1 2020 | $1,070,000 | +22.3% | 372,741 | +2.1% | 0.26% | +41.7% |
| Q4 2019 | $875,000 | +8.4% | 364,963 | -0.1% | 0.18% | +1.1% |
| Q3 2019 | $807,000 | +24.2% | 365,297 | +458.6% | 0.18% | +17.1% |
| Q2 2019 | $650,000 | +1.7% | 65,394 | +304.8% | 0.15% | -2.6% |
| Q1 2019 | $639,000 | -4.5% | 16,153 | -0.4% | 0.16% | -11.9% |
| Q4 2018 | $669,000 | +0.9% | 16,219 | -0.9% | 0.18% | -2.7% |
| Q3 2018 | $663,000 | +2.6% | 16,368 | +3.4% | 0.18% | +4.6% |
| Q2 2018 | $646,000 | -1.4% | 15,830 | -0.9% | 0.17% | -3.3% |
| Q1 2018 | $655,000 | +5.6% | 15,971 | -5.9% | 0.18% | +1.1% |
| Q4 2017 | $620,000 | +3.0% | 16,966 | +1.4% | 0.18% | -4.8% |
| Q3 2017 | $602,000 | -2.4% | 16,735 | +10.0% | 0.19% | -6.0% |
| Q2 2017 | $617,000 | 0.0% | 15,213 | 0.0% | 0.20% | 0.0% |
| Q1 2017 | $617,000 | +10.8% | 15,213 | +13.1% | 0.20% | +11.2% |
| Q4 2016 | $557,000 | -2.5% | 13,453 | -9.5% | 0.18% | -10.9% |
| Q3 2016 | $571,000 | -15.8% | 14,866 | -2.6% | 0.20% | -15.5% |
| Q2 2016 | $678,000 | +36.4% | 15,267 | +32.2% | 0.24% | -21.7% |
| Q1 2016 | $497,000 | -10.3% | 11,546 | -16.6% | 0.30% | -16.5% |
| Q4 2015 | $554,000 | -4.3% | 13,845 | -8.1% | 0.36% | -43.3% |
| Q3 2015 | $579,000 | -10.8% | 15,066 | -3.3% | 0.64% | -35.9% |
| Q2 2015 | $649,000 | -3.1% | 15,586 | +9.9% | 1.00% | -2.1% |
| Q1 2015 | $670,000 | – | 14,186 | – | 1.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |